SAT-3153

N/A

Report date: 2023/11/15 11:28:35
First In Class

Base Information

Drug NameSAT-3153
Drug Alias NameSAT-3153
ClassificationSmall molecules
Mechanisms of ActionProtein kinases inhibitorsAP2-associated protein kinase 1 inhibitors
TargetsProtein kinasesAP2-associated protein kinase 1
Therapy Area/IndicationsMuscular Dystrophy, Duchenne
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSatellos Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesSatellos Bioscience Inc
Inactive CompaniesN/A
Active IndicationsMuscular Dystrophy, Duchenne
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A